glp-1 announcement today The Vitamin Shoppe® Unveils First-of-its-Kind Supplement Line Formulated for Users CMS Expands Access to GLP-1

Popular GLP-1 Receptor Agonists Some of the well-known GLP-1 receptor agonists include: There are four GLP-1 agonist medicines approved by the Therapeutic Goods Administration (TGA) for use in Australia for the management of Type 2 Diabetes: dulaglutide (Trulicity) semaglutide (Ozempic) tirzepatide (Mounjaro) liraglutide (Saxenda)

Rising prevalence of diabetes worldwide, coupled with growing patient awareness and expanding healthcare access, is fueling market expansion

Hear from Zach Gall on our Texturants team as he dives into how these versatile sugar alcohols are helping formulators meet performance, labeling, and formulation goals across industries

The Canadian Journal of Anesthesiology recently published an editorial that included some recommendations

GLP-1R agonists now appear to be efficacious in reducing heart disease risk and in treating certain chronic kidney diseases, expanding their likely future use